LobbyingLife Sciences Pennsylvania lobbying by quarter
Life Sciences Pennsylvania's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Copyright/Patent/Trademark.
Life Sciences Pennsylvania
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $0 | 1 |
| Q1 2023 | $7,897 | 1 |
| Q2 2023 | $5,058 | 1 |
| Q3 2023 | $5,109 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $5,702 | 1 |
| Q2 2024 | $5,250 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$3,627 · 15 reports
- Copyright, patent and trademark$3,627 · 15 reports
- Health issues$3,627 · 15 reports
- Medical research and clinical labs$3,627 · 15 reports
- Medicare and Medicaid$3,627 · 15 reports
- Science and technology$3,627 · 15 reports
- Taxation$3,627 · 15 reports
- Insurance$3,627 · 11 reports
- Tariffs$0 · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseLife Sciences Pennsylvania | $29K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KURT IMHOF | VP, Policy and Public Affairs | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/07for Q2 | In-house | Under $5,000 |
| 04/20for Q1 | In-house | Under $5,000 |
| 01/29for Q4 2025 | In-house | Under $5,000 |
| 01/19for Q4 2025 | In-house | $6,000 |
| 25/10/20for Q3 2025 | In-house | Under $5,000 |
| 25/07/21for Q2 2025 | In-house | Under $5,000 |
| 25/04/21for Q1 2025 | In-house | Under $5,000 |
| 25/01/21for Q4 2024 | In-house | Under $5,000 |
| 24/10/21for Q3 2024 | In-house | Under $5,000 |
| 24/07/22for Q2 2024 | In-house | $5,250 |
| 24/04/22for Q1 2024 | In-house | $5,702 |
| 24/01/22for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | $5,109 |
| 23/07/20for Q2 2023 | In-house | $5,058 |
| 23/04/20for Q1 2023 | In-house | $7,897 |
| 23/04/06for Q1 2023 | In-house | Under $5,000 |
| 23/01/19for Q4 2022 | In-house | Under $5,000 |